Gavi expands into new areas as multi-billion-dollar COVID money bin continues to grow
The cash balance of the vaccine alliance Gavi keeps growing. Unspent COVID-19 funds could exceed USD 5 billion by next year, as the agency exits vaccine contracts. It also has access to a donor-sponsored credit line worth USD 2 billion. While Gavi has been tight-lipped about this growing pot of money, critics call for more transparency and a rethink of the Geneva-based agency. Read Development Today’s analysis.
